Administration of anti-Gr1 at the start of PbTg infection resulted in a significant reduction of CD8+ T cells, including IFNγ producing and non-producing CD8+ T cells (Table 1) but did not change the influx of CD4+ T cells within the brain (Fig 5A and 5Bc. The gene discussed is CD8A; the disease is infection.